For the Inventor, By the Inventor

Enter assignee name

Merck Frosst Canada & Co.

USPTO Granted Patents = 80

CIPO Patents = 1

Forward Citations = 562

Loading Chart...

Loading Chart...

144 inventors (with patents filed for the assignee):

Zhaoyin Wang (16 out of 50 patents)

Yves Leblanc (12 out of 40 patents)

Jacques Yves Gauthier (12 out of 34 patents)

4. Richard W Friesen (12 out of 27 patents)

5. Claude Dufresne (11 out of 24 patents)

6. Cheuk K Lau (11 out of 41 patents)

7. Cameron Black (9 out of 30 patents)

8. Daniel Guay (9 out of 35 patents)

9. Michel Therien (9 out of 37 patents)

10. Patrick Roy (9 out of 24 patents)

11. Chun Sing Li (8 out of 28 patents)

12. Yves Girard (8 out of 48 patents)

13. Richard Frenette (7 out of 27 patents)

14. Daniel Dube (7 out of 30 patents)

15. Erich L Grimm (7 out of 26 patents)

Core Competencies:

Cysteine Protease Inhibitors

Cyclooxygenase-2 Inhibitors

Phosphodiesterase-4 Inhibitors

Prostaglandin Receptor Antagonists

Protein Tyrosine Phosphatase Inhibitors

Granule Formation

Diaryl Compounds

Heterocyclic Compounds

Emesis Treatment

Nitric Oxide Releasing Prodrugs

Pyridine Derivatives

80 patents: Sort by Forward Citations

1. 8007830 - Granule formation (2011-08-30),

2. 7687524 - Cathepsin cysteine protease inhibitors (2010-03-30),

3. 7622502 - Nitric oxide releasing prodrugs of diaryl-2-(5h)-furanones as cyclooxygenase-2 inhibitors (2009-11-24),

4. 7622501 - Nitric oxide releasing prodrugs of diaryl-2-(5H)-furanones as cyclooxygenase-2 inhibitors (2009-11-24),

5. 7560559 - Polymorphic form of montelukast sodium (2009-07-14),

6. 7407959 - Cathepsin cysteine protease inhibitors (2008-08-05),

7. 7405229 - Cathepsin cysteine protease inhibitors (2008-07-29),

8. 7375134 - Cathepsin cysteine protease inhibitors (2008-05-20),

9. 7371747 - Cyanoalkylamino derivatives as protease inhibitors (2008-05-13),

10. 7365196 - Sulphonamido-substituted bridged bicycloalkyl derivatives (2008-04-29),

11. 7348433 - Quinolinones as prostaglandin receptor ligands (2008-03-25),

12. 7317036 - Fluoro substituted cycloalkanoindoles, compositions containing such compounds and methods of treatment (2008-01-08),

13. 7312353 - Cathespin cysteine protease inhibitors (2007-12-25),

14. 7279478 - Cathepsin cysteine protease inhibitors (2007-10-09),

15. 7163932 - Aryldifluoromethylphosphonic acids for treatment of diabetes (2007-01-16),

Merck Frosst Canada & Co. is a leading pharmaceutical company in Canada, focused on developing innovative prescription medications across a range of therapeutic areas. With a history dating back to the early 20th century, Merck Frosst has a strong commitment to research and development to improve the health and well-being of patients. The company is known for its expertise in areas such as oncology, infectious diseases, and cardiovascular health, and is dedicated to making a difference in the lives of Canadians through its high-quality pharmaceutical products.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

80 Patents

#13 in

#141 in Canada

#9,189 in the World

Merck Frosst Canada & Co.

Forward Citations = 562

144 inventors:

Zhaoyin Wang (16 out of 50 patents)

Yves Leblanc (12 out of 40 patents)

Jacques Yves Gauthier (12 out of 34 patents)

4. Richard W Friesen (12 out of 27 patents)

5. Claude Dufresne (11 out of 24 patents)

Please report any incorrect information to support@idiyas.com

Loading…